Shankar Vedantam, Drug Makers Prefer Silence On Test Data, Washington Post, July 6, 2004. Excerpt: "The pharmaceutical industry has repeatedly violated federal law by failing to disclose the existence of large numbers of its clinical trials to a government database, according to the Food and Drug Administration....The 1997 law is so little known that scientific journal editors and professional medical associations have recently debated whether to create a system of private incentives for disclosure of trials. When she was told the law already requires companies to register trials, Catherine DeAngelis, editor in chief of the Journal of the American Medical Association, said, 'That's a surprise to me. Tell me why it's not enforced.'...[Quoting Drummond Rennie, a professor at the University of California in San Francisco and editor at JAMA:] 'We give pharmaceutical companies a lot of tax advantages and a whole lot of support in the Congress and a good business environment and patent protection....They owe us more information.' "
Posted by
Peter Suber at 7/06/2004 12:07:00 AM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
